| P2093 | author name string | K F Wong | |
| | Stephenie Y N Wong | |
| P2860 | cites work | Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting | Q80832948 |
| | Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment | Q83981433 |
| | Three cases of fungemia in HIV-infected patients diagnosed through the use of mycobacterial blood culture bottles | Q85171725 |
| | Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum | Q93603657 |
| | Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects | Q24537359 |
| | Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay | Q24554498 |
| | Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004 | Q28274819 |
| | Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients | Q28290045 |
| | Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. | Q33495375 |
| | Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. | Q33672774 |
| | Disseminated Penicillium marneffei infection in an African AIDS patient | Q33909786 |
| | Indigenous disseminated Penicillium marneffei infection in the state of Manipur, India: report of four autochthonous cases | Q33962157 |
| | Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. | Q33974371 |
| | Profile of opportunistic infections among HIV-1 infected people in Hong Kong. | Q34058889 |
| | Disseminated Penicillium marneffei infection in southeast Asia | Q34059537 |
| | Osteoarticular penicilliosis marneffei. A report of eight cases and review of the literature | Q34328212 |
| | Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand | Q34368557 |
| | Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases | Q34398225 |
| | Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America | Q34974892 |
| | In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. | Q35135265 |
| | In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia | Q35220825 |
| | Rapid diagnosis of Penicillium marneffei infection by fine needle aspiration cytology | Q35769921 |
| | Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand | Q35938577 |
| | Disseminated Penicillium marneffei infection in HIV-infected subject. | Q36073233 |
| | Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. | Q36098525 |
| | Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. | Q36481206 |
| | Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers. | Q51570736 |
| | Hepatic penicilliosis in patients without skin lesions. | Q53354349 |
| | Application of nested PCR to detect Penicillium marneffei in serum samples. | Q54487193 |
| | Development of TaqMan real-time polymerase chain reaction for the detection and identification of Penicillium marneffei. | Q54495111 |
| | Cytological Diagnosis of Penicillium marneffei Infection | Q57610549 |
| | An efficacy study of itraconazole in the treatment of Penicillium marneffei infection | Q67872055 |
| | Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome | Q67967375 |
| | Fine needle aspiration diagnosis of Penicillium marneffei infection | Q68023839 |
| | Mycologic investigation on Rhizomys pruinous senex in Guangxi as natural carrier with Penicillium marneffei | Q69254778 |
| | Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus) | Q69666273 |
| | Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? | Q71120833 |
| | Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei | Q71327928 |
| | In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole | Q72770976 |
| | A French case of laboratory-acquired disseminated Penicillium marneffei infection in a patient with AIDS | Q72873132 |
| | Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole | Q73501653 |
| | [Penicillosis from Rhizomys sinensis] | Q74244692 |
| | Lymphadenopathy due to Penicillium marneffei infection: diagnosis by fine needle aspiration cytology | Q74755004 |
| | Cutaneous manifestations of Penicillium marneffei infection | Q77976532 |
| | Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system | Q78912730 |
| | Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART | Q79667562 |
| | Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei. | Q36517113 |
| | Diagnostic antigenemia tests for penicilliosis marneffei. | Q36540157 |
| | Immunoreactivity of a 38-kilodalton Penicillium marneffei antigen with human immunodeficiency virus-positive sera | Q36546164 |
| | Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers | Q36558221 |
| | In vitro activity of anidulafungin against selected clinically important mold isolates | Q37734590 |
| | Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei | Q38970862 |
| | Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients | Q39467744 |
| | Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicilliosis | Q39555177 |
| | Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers. | Q39558155 |
| | Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases | Q39652877 |
| | Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene | Q39664320 |
| | In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms | Q39743508 |
| | Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens | Q39882516 |
| | Role of Cannomys badius as a natural animal host of Penicillium marneffei in India | Q40283097 |
| | Penicilliosis in Vietnam: a series of 94 patients | Q40346922 |
| | Marrow penicilliosis: a readily missed diagnosis | Q40352792 |
| | A comparative analysis of the clinical and laboratory characteristics in disseminated penicilliosis marneffei in patients with and without human immunodeficiency virus infection | Q40402266 |
| | Acute abdomen: an unusual presentation of disseminated Penicillium marneffei infection | Q40420482 |
| | A 12-case series of Penicillium marneffei pneumonia. | Q40479342 |
| | Penicilliosis in Laos | Q40483428 |
| | Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient | Q40490123 |
| | Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India | Q40571199 |
| | Late manifestations of HIV in Asia and the Pacific | Q40594103 |
| | Serodiagnosis of Penicillium marneffei infection | Q40697387 |
| | Penicilliosis marneffei in Thailand: report of five human cases. | Q40826143 |
| | The pharmacokinetics of oral itraconazole in AIDS patients | Q41090651 |
| | Cutaneous manifestations of disseminated Penicillum marneffei mycosis in five HIV-infected patients* | Q41153444 |
| | Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. | Q41581886 |
| | Genital ulcer caused by Penicillium marneffei in an HIV-infected patient | Q43158713 |
| | Infection Caused byPenicillium marneffei: Description of First Natural Infection in Man | Q43811748 |
| | Clinicopathologic study of hepatic Penicillium marneffei in Northern Thailand | Q44736903 |
| | Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. | Q44930714 |
| | A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus | Q45145992 |
| | Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy. | Q45419088 |
| | Penicillium marneffei infection presenting as oral ulcerations in a patient infected with human immunodeficiency virus | Q45736330 |
| | Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand | Q45762390 |
| | Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity | Q45876828 |
| | Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis. | Q46032916 |
| | In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei | Q46215261 |
| | Hemophagocytic syndrome in a patient with acquired immunodeficiency syndrome and acute disseminated penicilliosis. | Q46813623 |
| | Specific identification of Penicillium marneffei by a polymerase chain reaction/hybridization technique | Q48015846 |
| | In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine | Q48866702 |
| | Musculoskeletal Manifestations of HIV Infection in Thailand: An Analysis of 100 Cases. | Q50133306 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Talaromyces marneffei | Q2317277 |
| P304 | page(s) | 764293 | |
| P577 | publication date | 2011-02-10 | |
| P1433 | published in | Pathology Research International | Q26853836 |
| P1476 | title | Penicillium marneffei Infection in AIDS. | |
| P478 | volume | 2011 | |